Page 15 - Introduction to FMT
P. 15

FMT Introduction





         Though FMT is relatively easy to perform, there is wide inter-institutional variability in methodology. For
         example, in preparation for FMT, some institutions give their patients multiple doses of doxycycline or
         vancomycin in an effort to reduce the native, dysbiotic population [29]. In many institutions, immediately
         prior to FMT, patients are typically given a polyethylene glycol colon preparation to increase the
         opportunity for the transplanted microbiome to successfully colonize the gut regardless of whether the
         FMT is introduced in the upper GI tract or through a colonoscopy. However, there is no published
         evidence suggesting that this preparation improves FMT clinical outcomes [22].



         The processing of fecal matter for transplant is not standardized and needs to be experimentally
         validated for optimal efficacy. The general principal, however, is more or less universal. As outlined in
         Figure 1, the donated stool is first mixed with saline solution to homogenize it into a liquid sample, and is
         then filtered to remove any solid feces that may interfere with the transplant. In order to standardize the
         processing of fecal matter, studies have compared the efficacy of frozen versus fresh stool samples prior
         to processing and transplantation. These studies have thus far shown no significant difference in primary
         outcomes [30,31]. While studies have performed 16s rRNA sequencing before and after processing to
         evaluate sample loss, fecal matter contains 99 percent anaerobic species which may not survive vigorous
         aerobic blending [32,33]. Furthermore, 16s rRNA sequencing does not discriminate viable from dead cells.
         Nevertheless, the overwhelming number of positive results obtained from FMT in treating CDI patients
         suggests that either the viability of the cells is relatively unimportant, or that a small proportion of
         survived cells is sufficient to induce a change in the recipient’s microbiome and a therapeutic effect.


         Figure 1



         Fecal Microbiota Transplantation schematic. A) Donor fecal matter is blended with saline solution and
         pushed through a metal sieve to achieve a homogenous liquid solution. B) Processed fecal microbiota is
         either delivered via a duodenal tube or colonoscopy. C) Representative data showing metagenomic
         diversity increases following FMT from lean donor to obese recipient.








































                                                 FMT Introduction
   10   11   12   13   14   15   16   17   18   19   20